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Abstract
Objective Narcolepsy is a lifelong disease, manifesting with excessive daytime sleepiness and cataplexy, arising between
childhood and young adulthood. The diagnosis is typically made after a long delay that burdens the disease severity. The aim
of the project, promoted by the “Associazione Italiana Narcolettici e Ipersonni” is to develop Red Flags to detect symptoms for
early referral, targeting non-sleep medicine specialists, general practitioners, and pediatricians.
Materials and methods A multidisciplinary panel, including patients, public institutions, and representatives of national scien-
tific societies of specialties possibly involved in the diagnostic process of suspected narcolepsy, was convened. The project was
accomplished in three phases. Phase 1: Sleep experts shaped clinical pictures of narcolepsy in pediatric and adult patients. On the
basis of these pictures, Red Flagswere drafted. Phase 2: Representatives of the scientific societies and patients filled in a form to
identify barriers to the diagnosis of narcolepsy. Phase 3: The panel produced suggestions for the implementation of Red Flags.
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Results Red Flags were produced representing three clinical pictures of narcolepsy in pediatric patients ((1) usual sleep symp-
toms, (2) unusual sleep symptoms, (3) endocrinological signs) and two in adult patients ((1) usual sleep symptoms, (2) unusual
sleep symptoms). Inadequate knowledge of symptoms at onset by medical doctors turned out to be the main reported barrier to
diagnosis.
Conclusions This report will hopefully enhance knowledge and awareness of narcolepsy among non-specialists in sleepmedicine
in order to reduce the diagnostic delay that burdens patients in Italy. Similar initiatives could be promoted across Europe.
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Introduction
Narcolepsy is characterized by the pentad of excessive day-
time sleepiness, cataplexy, hypnagogic or hypnopompic hal-
lucinations, sleep paralysis, and disrupted nighttime sleep
[1–3]. It is a chronic and disabling disorder, with a bimodal
peak for age at onset, with a maximal rate of onset at 15 years
and the second peak at 35 years, needing a lifelong treatment
[4].
Narcolepsy has a prevalence between 20 and 50 per
100,000 [5–11] and is recognized as rare disease (RF 0150)
by the Italian Ministry of Health [attachment 1 at DM N. 279/
2001]. At December 31, 2014, 610 patients were recorded in
Italy by the National Registry for Rare Diseases [12], with an
average national annual incidence in the 3-year period 2012–
2014 of 0.97 per 1 million person-years [13] compared to an
annual incidence of 1.37 per 100,000 person-years in Olmsted
County, Minnesota (USA) [7].
The current classification [1] distinguishes narcolepsy type 1
(NT1) and narcolepsy type 2 (NT2). Both types feature daytime
sleepiness confirmed by polysomnographic studies, while
hypocretin level of less than 110 pg/mL and the presence of
cataplexy characterize only NT1. Therefore, NT1 is linked to
the loss of hypothalamic hypocretinergic neurons, while the
cause ofNT2 remains unknown.Both genetic and environmental
factors play a crucial role in the pathogenesis of narcolepsy.Most
patients with narcolepsy carry HLA-DQB1*0602 and a link to
polymorphisms in other non-HLAgenes that may affect immune
regulatory function and to several infectious triggers, supporting
an autoimmune pathogenesis [2, 3].
Although narcolepsy has an early onset, a diagnostic delay
that often exceeds 10 years from symptoms onset is reported
[14–18]. Lately, there has been a trend toward a shorter diag-
nostic delay, which could potentially be attributed to an in-
creased awareness of narcolepsy, as for example in Italy
through media campaigns [https://www.narcolessia.org].
However, as emerged from a recent survey conducted by the
Italian association of patients with narcolepsy and hypersomnia
(Associazione Italiana Narcolettici e Ipersonni – AIN; https://
www.narcolessia.org), diagnostic delay continues to be an
issue, which makes identifying its causes a priority.
Data from several studies and reviews suggest that the prima-
ry reason for diagnostic delay is likely the lack of symptoms
recognition, often resulting in misdiagnosis [14–16, 18–22].
This may originate from several factors, including lack of recog-
nition, on the part of the clinician, of the signs and symptoms of
narcolepsy, leading to multiple referrals before receiving a proper
diagnosis [14, 20–22] as well as misdiagnosis of narcolepsy as
another condition, such as epilepsy, depression, or attention-def-
icit/hyperactivity disorder, which further delays treatment [14,
19, 20, 23, 24].
Receiving a correct narcolepsy diagnosis is especially
relevant in children, in order to timely face consequences,
such as low academic achievement and social difficulties
[18]. This is an important pitfall to be addressed, as mis-
diagnosis is more common in pediatric narcolepsy [19,
20, 25]. Indeed, the strongest predictor of a delayed diag-
nosis, along with the absence of cataplexy, has been re-
ported to be pediatric onset of symptoms [26]. Diagnosis
of narcolepsy indeed may be particularly challenging in
children as symptoms may manifest differently from
adults. Excessive daytime sleepiness can manifest as at-
tentional problems, paradoxical hyperactivity, elongation
of nighttime sleep, and resuming of postprandial sleep [3].
Hallucinations can be underrecognized because of the dif-
ficulty for children to recognize and describe them and for
the possible coexistence of nightmares, rapid eye move-
ment (REM) sleep behavior disorder (RBD), sleep terrors,
and confusional arousals [26, 27]. Children with NT1 may
have peculiar features of cataplexy with subcontinuous
hypotonia, mainly involving the facial district “cataplectic
face” and superimposed dyskinesia [23, 24, 28].
Timely diagnosis means better outcomes and it has been
reported that patients diagnosed before age 30 years exhibit
lower unemployment rates and have better health perception
than those diagnosed at a later age [29], therefore resulting in
reduced psychological distress along with socioeconomic and
healthcare consequences [30–34]. Accordingly, it is important
to understand the reason of this pitfall in diagnosis and to act
in order to correct this gap and improve the rate of a timely
diagnosis.
Considering these premises and the result of the above-
mentioned AIN survey, AIN itself has promoted this
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document with the specific aim of exploring, at multiple levels
of the healthcare system, the causes of diagnostic pitfalls and
of proposing corrective actions. We propose of doing this
through Red Flags aimed at detecting narcolepsy symptoms
early and timely referring potentially affected individuals to
specialist care.
Objective
The aim of the project is to develop Red Flags to improve the
knowledge about the symptoms suggestive of narcolepsy
among non-sleep medicine expert physicians potentially in-
volved in the first referral of patients (neurologists, pediatric
neurologists, general practitioners, and pediatricians) for early
referral to sleep medicine centers. The focus is the definition
of the exemplary (chief complaint) and atypical (variant
complaint) clinical presentations of narcolepsy, at its onset
or when fully developed, in children and in adults. The anal-
ysis of barriers and facilitators of the diagnostic suspicion of
narcolepsy was carried out with the aim of suggesting strate-
gies for the implementation of the Red Flags.
Methods
The current document is a position paper, promoted by AIN,
based on experts’ and stakeholders’ opinions. The following
scientific societies endorsed the project by appointing a repre-
sentative member of each society: the Italian society of neu-
rology (Società Italiana di Neurologia, SIN; P. C.); the Italian
society of pediatric neurology (Società Italiana Neurologia
Pediatrica, SINP; V. M.); the Italian society of social and pre-
ventive medicine (Società Italiana di Pediatria Preventiva e
Sociale, SIPPS; M.C. V.); the Italian society of pediatrics
(Società Italiana di Pediatria, SIP; E. V.); the Italian society
of general practitioners (Società Italiana di Medicina
Genera le , SIMG; M. B.) ; the I ta l ian socie ty of
neurophychiatrists for children and adolescents (Società
italiana di neuropsichiatria dell’infanzia e dell’adolescenza,
SIMPIA; R. G., F. M.); the World Association of Sleep
Medicine (WASM; L. F-S.); the Italian association of sleep
medicine (Associazione Italiana Medicina del Sonno, AIMS;
R. F.), the Italian association of healthcare managers
(Associazione Nazionale Medici di Direzione Ospedaliera;
ANMDO; G. P.). A scientific committee was established, in-
cluding a patients’ representative (I. C., AIN), methodology
experts from IRCCS Istituto delle Neuroscienze di Bologna
(L. V.) and Italian institute of health - National Centre for Rare
Diseases (Istituto Superiore di Sanità, ISS: C. C., D. T.), and
narcolepsy experts (E. A., F. P., F. I., L. F-S., R. F. and G. P.).
The document was planned at an initial meeting of the
scientific committee and scientific societies spokespersons in
Bologna (Italy), July 21, 2017. Three phases were conceived:
(1) Red Flags editing; (2) barriers and facilitators analysis; (3)
suggestions for Red Flags implementation.
Red Flags editing
Based on the AASM ICSD 3 [1] criteria for narcolepsy and
by consulting evidence-based summaries [35–37], sleep ex-
perts defined the exemplary and atypical clinical pictures of
narcolepsy, at onset or fully developed, in children and in
adults. In particular, each Red Flag was edited as a short
statement including the alerting symptom(s), either according
to the possible chief complaints or the possible variant com-
plaints. An explanation box, reporting examples of real-life
presentation of symptoms, equipped each Red Flag. For each
piece of evidence at the basis of the statement, the possible
references labeled with their study design were reported. A
first draft was submitted to the whole members group and a
final consensus version was achieved. Red Flags were edited
in Italian then translated into English (See Supplementary
Material).
Barriers and facilitators analysis
An electronic questionnaire was built to investigate barriers
and facilitators of the diagnostic suspicion of narcolepsy. The
questionnaire was designed according to the “Tailored
Implementation for Chronic Diseases” (TICD) checklist
[38], a comprehensive tool that identifies determinants, that
is barriers and facilitators, of healthcare professional practice.
Briefly, it includes 57 potential determinants of practice,
grouped in seven domains (guideline factors; individual health
professional factors; patient factors; professional interactions;
incentives and resources; capacity for organizational change;
and social, political, and legal factors). The scientific commit-
tee chose the relevant domains and determinants conceivably
involved in the diagnostic process of patients with suspicion
of narcolepsy. Each determinant was transformed as question
with a 4-point Likert scale (possible answers: “strongly
agree,” “agree,” “disagree,” “strongly disagree”). The check-
list was then edited in three versions and submitted to the
scientific societies spokespersons, child patient caregivers,
and adult patients. Patients and caregivers were invited by
AIN.
Suggestions for Red Flags implementation
A list of suggestions aiming at the implementation of the Red
Flags, based on the results of the Phase 2 analysis, was edited
by the whole group during a final meeting.
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Results
Red Flags were produced representing three clinical pictures of
narcolepsy in children (picture with (1) usual sleep symptoms,
(2) unusual sleep symptoms, (3) metabolic symptoms) and two
in adults (picture with (1) usual sleep symptoms, (2) unusual
sleep symptoms). See Supplementary Material for original ver-
sion in Italian.
Red flags for pediatric patients
Narcolepsy should be suspected in pediatric patients that pres-
ent with…
1. Excessive daytime sleepiness and/or cataplexy (see
Tables 1 and Table 2 for explanations).
➔In this case, it is recommended that the patient should be
referred to the reference centers for the diagnosis.
2. peculiar sleep-related disorders, i.e., hypnagogic-
hypnopompic hallucination, sleep paralysis, and im-
paired nocturnal sleep (see Table 3 for explanations).
➔ In this case, it is recommended that the presence of ex-
cessive daytime sleepiness and cataplexy (as indicated in Red
Flag 1) should be investigated, even if these symptoms are not
directly reported by the patient. In case of positive history of
excessive daytime sleepiness and/or cataplexy, it is recommend-
ed that the patient should be referred to the reference centers for
the diagnosis
Table 1 Explanation of pediatric patients Red Flag 1 on excessive
daytime sleepiness. This Red Flag was formulated based on core
literature consisting of the international diagnostic criteria [1], one
evidence-based clinical summary [36], three reviews [3, 39, 40], one
cohort study [24], one incidence cross-sectional study [41], one case
report [42]
In pediatric patients excessive daytime sleepiness may present with:
•… sleep attacks, occurring in unusual and non-monotonous conditions,
usually of brief duration, with a refreshing effect and with the recall of
vivid dreams
• .. change (acute or progressive) of sleep-wake circadian rhythmwith
the tendency to increase the total sleep hours per day, to resume the
habitual napping that occurs beyond the age when a child typically
grows out of the need for daily naps (i.e. after five to six years of age),
to go to sleep earlier and to wake up later and with major difficulties in
the morning awakening
• … onset during daytime of hyperactivity, inattention, irritability and
automatic behaviors. Those symptoms are more easily observable at
school, as for example the child progressively starts writing with a
shoddy handwriting or with incomprehensible spelling until
interrupting completely the handwriting
It should be kept in mind that in children the most frequent differential
diagnoses of these symptoms are chronic sleep deprivation,
psychological problems, seizures, infectious encephalopathies.
Therefore, if one or more of these conditions are suspected, narcolepsy
should also be considered in the differential diagnosis.
Table 2 Explanation of pediatric patients Red Flag 1 on cataplexy. This
Red Flag was formulated based on core literature consisting of the
international diagnostic criteria [1], one evidence-based clinical
summary [36], one review [3], one cohort study [24], two case-series
[23, 28], two case reports [43, 44]
In pediatric patients cataplexy may present with:
• … brief (seconds-minutes) episodes of loss of muscle tone triggered by
emotions, during wakefulness. The loss of muscle tone can be partial
(eyelid ptosis, mouth opening, tongue protrusion, head drop, slurred
speech, trunk drop) and/or generalized (up to fall to the ground)
• … cataplectic face, droopy expression, with the nearly constant but
fluctuating presence of eyelid ptosis, mouth opening, tongue
protrusion. Cataplectic face may be present sub-continuously with
intermittent exacerbation due to daily life activities (i.e. eating, playing
or being involved in an activitywith emotional involvement, as playing
with videogames, watching a funny movie, etc.)
• … floppy aspect, that may involve mainly the head and the trunk (with
intermittent episodes of head and trunk drops) or all the body and the
legs appearing limply with a wobbly, wide-based, unstable, ataxic-like
gate
• intermittent active movements, mainly involving the face (grimacing,
eyebrow raising, perioral dyskinesias, tongue thrusting movements,
tongue protrusion) or the body (stereotypies and choreic-like
movements)
It should be kept in mind that in pediatric patients the most frequent
differential diagnoses of these symptoms are neuromuscular disorders
and hyperkinetic movement disorders. Therefore, if such conditions are
suspected, narcolepsy should also be considered in the differential
diagnosis. The fluctuating character (not triggered by exercise) and the
association with excessive daytime sleepiness may help in differential
diagnosis.
Table 3 Explanation of pediatric patients Red Flag 2 on peculiar sleep-
related disorders. This Red Flag was formulated based on core literature
consisting of the international diagnostic criteria [1], one evidence-based
clinical summary [36], two reviews [3, 45], four case-series [46–49]
In pediatric patients peculiar sleep-related disorders may present with:
• Multimodal hallucinations (mainly visual) or illusions that appear at
sleep onset (hypnagogic) or on awakening (hypnopompic)
• Vivid dreams, mainly with frightening contents
• Sleep paralyses, i.e. inability tomove for one or twominutes immediately
after awakening or just before falling asleep, accompanied by a
disquieting sensation with or without concomitant hallucinations/illusions
• Impaired nocturnal sleep, with agitations, fragmented sleep andREM
sleep behavior disorder (RBD), i.e. with the presence of movements
that mimic the dream content (enacted dreams) (i.e. the patient moves
as if he/she were acting what he/she is dreaming; upon awakening
he/she recalls a vivid dream coherent with the performed movements)
It should be kept in mind that in pediatric patients in the full-blown
disorder, these symptoms are usually accompanied by excessive
daytime sleepiness and cataplexy. It is rare, but possible, that these
symptoms represent the initial manifestations of the disease. In
children, given the low insight and the embarrassment in reporting
unpleasant or embarrassing experiences, these are rarely reported
spontaneously and difficult to investigate.
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3. signs of precocious puberty and/or increase of weight
until the development of obesity (see Table 4 for
explanations).
➔ In this case, it is recommended that the presence of
excessive daytime sleepiness and cataplexy (as indicated in
Red Flag 1) should be investigated, even if these symptoms
are not directly reported by the patient. In case of positive
history of excessive daytime sleepiness and/or cataplexy, it is
recommended that the patient should be referred to the refer-
ence centers for the diagnosis.
Red flags for adult patients
Narcolepsy should be suspected in adult patients that present
with…
1. Excessive daytime sleepiness and/or cataplexy (see
Tables 5 and 6 for explanations).
➔In this case, it is recommended that the patient should be
referred to the reference centers for the diagnosis.
2. peculiar sleep-related disorder, i.e., hypnagogic-
hypnopompic hallucination, sleep paralysis, and im-
paired nocturnal (see Table 7 for explanations).
➔ In this case, it is recommended that the presence of
excessive daytime sleepiness and cataplexy (as indicated in
Red Flag 1) should be investigated, even if these symptoms
are not directly reported by the patient. In case of positive
history of excessive daytime sleepiness and/or cataplexy, it is
recommended that the patient should be referred to the refer-
ence centers for the diagnosis.
Barriers and facilitators analysis
The following domains and determinants were selected from
the TICD checklist to design and to analyze questionnaire
results: (a) individual health professional factors (knowledge
and skills; cognition and attitudes; professional behavior); (b)
patient factors (needs; beliefs and knowledge; preferences;
motivation; behavior); (c) professional interactions (referral
processes); (d) incentives and resources (nonfinancial incen-
tives and disincentives; assistance for clinicians); (e) capacity
for organizational change (regulations, rules policies); (f) so-
cial, political, and legal factors (legislation).
Scientific societies spokespersons
Five specialist spokespersons completed the survey (a general
practitioner, a neurologist, a child neuropsychiatrist, a child
neurologist, a general pediatrician).
For most specialists, main barriers of diagnostic suspi-
cion of narcolepsy are the insufficient knowledge of
symptoms at onset, and the insufficient skill or propensity
to examine symptoms when they are considered atypical
(elongation of 24-h sleep, hallucinations, cataplexy,
Table 4 Explanation pediatric patients Red Flag 3 on endocrinological
signs. This Red Flagwas formulated based on core literature consisting of
the international diagnostic criteria [1], one evidence-based clinical
summary [36], one review [3], one cohort study with controls [50], one
retrospective cohort study [51], one cross-sectional study with controls,
[52], one case-series [53]
In children, near to the onset, narcolepsy can be accompanied by
endocrinological signs, i.e. acceleration/anticipation of pubertal signs
until reaching criteria for precocious puberty and the progressive
increase of weight until reaching the criteria for obesity. In these
conditions therefore, it is recommended that the symptoms of
narcolepsy should be investigated as reported in Red Flags 1 e 2.
Table 5 Explanation of adult patients Red Flag 1 on excessive daytime
sleepiness. Red Flag 1 on excessive daytime sleepiness was formulated
based on core literature consisting of the international diagnostic criteria
[1], two evidence-based clinical summaries [35, 37], one review [2]
In adult patients excessive daytime sleepiness may present with:
•… sleep attacks, occurring in unusual and non-monotonous conditions,
usually of brief duration, with a refreshing effect and with the recall of
vivid dreams
•... change (acute or progressive) of sleep-wake circadian rhythmwith
the tendency to increase the total sleep hours per day and to be prone to
fall asleep throughout the day, often at inappropriate times
It should be kept in mind that in adults the most frequent differential
diagnoses for these symptoms are obstructive sleep apnea, chronic
sleep deprivation, psychological problems, and seizures. Therefore, if
one or more of these conditions are suspected, narcolepsy should also
be considered in the differential diagnosis.
Table 6 Explanation of adult patients Red Flag 1 on cataplexy. This
Red Flag was formulated based on core literature consisting of the
international diagnostic criteria [1], two evidence-based clinical
summaries [35, 37], one review [2], three case-series [54–56].
In adult patients cataplexy may present with:
• … brief (seconds-minutes) episodes of loss of muscle tone triggered by
emotions, during wakefulness. The loss of muscle tone can be partial
(eyelid ptosis, mouth opening, tongue protrusion, head drop, slurred
speech, trunk drop) and/or generalized (up to fall to the ground)
• … transient episodes (seconds-minutes) with speech and action arrest
without a clear hypotonia, but always with retained consciousness.
It should be kept in mind that in adult patients the most frequent
differential diagnoses of these symptoms are seizures and
cerebrovascular attacks. Therefore, if such conditions are suspected,
narcolepsy should also be considered in the differential diagnosis. The
absence of an aura and the integrity of consciousness in narcolepsy
may help in the differential diagnosis.
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nighttime sleep disruption with rapid eye movement
(REM) sleep behavior disorder, sleep terrors) or when
they are reported as disease consequences (attentional
problems, paradoxical hyperactivity, worsening of school
or work performances). Another barrier is represented by
the difficult referral process to expert sleep centers, due to
the geographical distance or the difficulty of booking an
appointment. Social or legal factors are not deemed as a
relevant cause of the diagnostic delay; however, the fear
of losing the driving license was raised by one specialist
as a possible diagnostic barrier. Possible facilitators are
tools to elicit the diagnostic suspicion or to improve the
knowledge (questionnaires and educational materials,
both printed and on the web; toll-free number) and orga-
nizational changes to simplify the access to expert sleep
centers (dedicated outpatients’ clinic; diagnostic–
therapeutic pathway).
Pediatric patients
Twenty-three caregivers of pediatric patients (14 males/9 fe-
males) completed the survey; narcolepsy type 1 was the prev-
alent diagnosis (21). The sample was quite homogeneously
distributed in the Italian areas (north west 39%; north east
14%; middle 30%; south and islands 17%). Median age at
onset was 9 years, and mean diagnostic delay 2.1 years (SD
3.5; median 1; range 0–14). Narcolepsy was not suspected at
the first visit in 61% of patients; 47% of them consulted more
than two physicians, and up to 10 in one case. Reported alter-
native diagnoses (in 48% of patients) are other organic disor-
ders (epilepsy, obstructive sleep apnea syndrome, brain neo-
plasm, iron deficiency, drug abuse, tics, precocious puberty),
psychological problems, abnormal attitudes/behaviors
(boredom, laziness).
Main barrier to the diagnostic suspicion of narcolepsy was
the inadequate knowledge of the disease by physicians (see
Table 8). Relevant was also the scarce awareness of symptoms
in their child by parents. To be noticed, the presence of more
Table 7 Explanation of adult patients Red Flag 2 on peculiar sleep-
related disorders. This Red Flag was formulated based on core literature
consisting of the international diagnostic criteria [1], two evidence-based
clinical summaries [35, 37], three reviews [2, 57, 58], two case-series [59,
60]
In adult patients peculiar sleep-related disorders may present with:
•Multimodal hallucinations (mainly visual) or illusions which present at
sleep onset (hypnagogic) or on awakening (hypnopompic)
• Sleep paralyses, i.e. inability to move for one or two minutes
immediately after awakening or just before falling asleep,
accompanied by a disquieting sensation with or without concomitant
hallucinations/illusions
• Impaired nocturnal sleep, with agitations, fragmented sleep andREM
sleep behavior disorder (RBD), i.e. with the presence of movements
that mimic the dream content (enacted dreams) (i.e. the patient moves
as if he/she were acting what he/she is dreaming; upon awakening
he/she recalls a vivid dream coherent with the performed movements)
It should be kept in mind that in adult patients these symptoms may occur
as isolated phenomena, such as for example isolated idiopathic RBD
or RBD in neurodegenerative conditions. However, in presence of one
or more of these conditions, the co-occurrence of excessive daytime
sleepiness and of cataplexy should also be investigated.
Table 8 Main barriers of diagnostic suspicion of narcolepsy according to caregivers of pediatric patients and adult patients
Determinants (domain and specific determinant) Judged as relevant
(% out of 23 pediatric
patients’ caregivers)
Judged as relevant
(% out of 48
adult patients)
Patient factors (beliefs and knowledge; behavior)
Scarce awareness of symptoms by parents/patients 61% 64%
Individual health professional factors (knowledge and skills)
Insufficient knowledge of the disease 79% 69%
Professional interactions (referral processes)
Difficult access to expert sleep center 26% 23%
Social, political, and legal factors
Social factors or legislation as barriers of the healthcare process 4% 34%
Barriers of diagnostic suspicion (open question)
Insufficient knowledge of the disease by the physician 46% 55%
No awareness of symptoms by parents/patients 13% 12%
More popular competing disorders 8% 11%
Prejudices/social barriers 8% 8%
No knowledge of specialist centers – 2%
None/no response 25% 12%
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popular competing disorders (see above) among the possible
barriers to diagnostic suspicion.
Adult patients
Forty-eight adult patients (25 males/23 females) complet-
ed the survey; narcolepsy type 1 was the prevalent diag-
nosis (32). The sample was quite homogeneously distrib-
uted in the Italian areas (north west 26%; north east 22%;
middle 22%; south and islands 30%). Median age at onset
was 11 years, mean diagnostic delay 6.7 years (SD 7.3;
median 3.5; range 0–42). Narcolepsy was not suspected at
first visit in 67% of patients; 59% of them consulted more
than two physicians, and up to 10 in three cases. Reported
alternative diagnoses (in 48% of patients) included other
organic disorders (42%: epilepsy, obstructive sleep apnea
syndrome, restless leg syndrome, gastroesophageal reflux,
post-viral syndrome, obesity) and psychiatric disorders
(43%: depression, anxiety), abnormal attitudes/behaviors
(15%: laziness, tiredness).
Main barrier to the diagnostic suspicion of narcolepsy
is the insufficient knowledge of the disease by physicians
(see Table 8) and the scarce awareness of symptoms by
patients. To be noticed, the presence of more popular
competing disorders among the possible barriers to diag-
nostic suspicion. The presence of social/legislation factors
(not acceptance of the disease, fear of social and work
limitations, fear of driving license loss) is also reported
as relevant by 1/3 of patients.
Suggestions for Red Flags implementation
After the analysis of the above reported data, the multidisci-
plinary panel agreed on the following suggestions to imple-
ment the above reported Red Flags.
& The Red Flags should be the object of a national cam-
paign, with presentation at national congresses and meet-
ings and publications in Italian journals targeted to the
specialties relevant to the project.
& The Red Flags should be disseminated with simple edu-
cational materials, such as leaflets with cartoons or as web
movies that can be distributed in primary care centers, or
at school, where symptoms can be firstly recognized.
& To facilitate the access to the reference centers, in collab-
oration with the National Helpline on Rare Diseases
(Telefono Verde Malattie Rare 800 89 69 49) of the
Istituto Superiore di Sanità (National Centre for Rare
Diseases), a national central call-center could be designed
in order to drive and help clinicians in referring the pa-
tients to the nearest and more appropriate center.
& The recognition of the symptoms by physicians could be
elicited by validated questionnaires. Due to the scarcity of
these tools in the Italian language (e.g., [61, 62] consider-
ing only excessive daytime sleepiness), a tool including
the whole Red Flags should be devised and validated.
& The efficacy of the Red Flags implementation in reducing
the diagnostic gap of patients with narcolepsy could be the
object of a national multi-center study (e.g., an interrupted
time series study).
& Similar initiatives could be promoted across European
countries.
Discussion
Narcolepsy is still a disease burdened by an unacceptable
diagnostic delay [18, 26] and possibly by missed diagnoses
in Italy [12, 13].
The persistence of a substantial delay in recognizing
symptoms of narcolepsy, even among sleep medicine spe-
cialists, has been highlighted also by the Awareness and
Knowledge of Narcolepsy (AWAKEN) study [21]. This is
a survey including a sample of 1000 US adults, 300 primary
care physicians (PCPs), and 100 sleep medicine specialists
conducted in the USA. The study showed that even if 62%
of sleep specialists and 24% of PCPs considered themselves
“very” or “extremely” knowledgeable about narcolepsy,
only 42% and 9% of sleep specialists and PCPs, respective-
ly, felt “very” or “extremely” comfortable diagnosing the
disorder. The striking finding was however that only 22%
of sleep specialists and 7% of PCPs identified all 5 key
narcolepsy symptoms; particularly, while excessive day-
time sleepiness and cataplexy were more easily recognized,
the other symptoms were instead more rarely investigated
and recognized.
An Italian survey disclosed that pediatricians and child
neuropsychiatrists scored low in all areas of sleep knowledge
and particularly in questions about narcolepsy, sleep apnea,
and parasomnias [63].
In order to reach patients’ needs and overcome the diag-
nostic gap, AIN has promoted the initiative at issue aiming at
analyzing the reasons that hamper a timely diagnosis and to
offer to general clinicians, pediatricians, and neurologists a
document containing Red Flags that can help in a prompt
recognition of symptoms that can lead to suspect narcolepsy,
in order to refer the patient to the reference centers for the
diagnosis.
As far as barriers analysis is concerned, results of question-
naires confirmed that both patients and clinicians judged lack
of knowledge of symptoms as a main factor hampering a right
and timely diagnosis. Particularly, as emerged also in the
AWAKEN study [21], the scarce knowledge about symptoms
different from excessive daytime sleepiness and cataplexy
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emerges as one of the main causes in delaying the proper
recognition of the disease.
Indeed, in more than 60% of both pediatric and adult pa-
tients, narcolepsy was not suspected at the first outpatient
evaluation; and therefore nearly 60% of patients needed to
consult more than two physicians. In over 50% of cases, a
diagnosis of different organic conditions (epilepsy, sleep ap-
nea, brain lesions) or of a psychiatric condition was made.
Noteworthy, what came to light from our survey was the
shorter mean diagnostic delay in Italy compared to other
European data (namely 2.1 years for pediatric cases and
6.7 years for adults). This could be due to the shortening of
the delay in the last years (note the difference between chil-
dren and adults), also thanks to awareness campaigns on nar-
colepsy that AIN has been promoting since 2000. These data
could also be biased by the small sample size and the recruit-
ment process (voluntary).
Considering the differences in phenotypic presentations in
adults and children, different sets of Red Flags have been
produced for the two populations and we distinguished two
different scenarios: the first one with symptoms that are al-
ready sufficient to suspect the diagnosis and two additional
conditions for children and one for adults that concern asso-
ciated symptoms in which we recommend instead to investi-
gate the presence of excessive daytime sleepiness and cata-
plexy, prior referring patients to the reference centers for the
diagnosis.
The panel focused particularly in defining the peculiar fea-
tures of narcolepsy in children and mainly the discrete mani-
festation of excessive daytime sleepiness, which not always
presents with sleep attacks and the typical phenotype of cata-
plexy in children.
Indeed, the best predictor of a delayed diagnosis, along
with the absence of cataplexy, is known to be the pediatric
onset of symptoms [26]. This is because pediatric narcolepsy
near the onset of the disease may have peculiar features [3,
36], as excessive daytime sleepiness may be manifested as
paradoxical hyperactivity, elongation of nighttime sleep, re-
sume of post prandial sleep and symptoms like hallucinations,
RBD, and confusional arousals may be difficult to be articu-
lated by children [26, 27]. Similarly, cataplexy at onset may
present with the peculiar subcontinuous hypotonia and
“cataplectic face” with superimposed dyskinesia or motor hy-
peractivity resembling other neurodevelopmental disorders
[23, 24, 28].
Experts also focused on the description of symptoms differ-
ent from excessive daytime sleepiness and cataplexy, since both
the AWAKEN survey [21] and our own survey highlighted that
clinicians may be more confident in investigating the cardinal
features of narcolepsy (i.e., excessive daytime sleepiness and
cataplexy), while less so in identifying the remaining symptoms
typical of the narcolepsy pentad, i.e., hallucinations, sleep pa-
ralysis, and disrupted nocturnal sleep with RBD.
This report, by producing Red Flags guiding in suspecting
the diagnosis of narcolepsy, has been therefore an attempt to
overcome the major barriers identified through the survey.
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